Katalysen Ventures (KAV) Q4 2024 earnings summary

Executive summary

• Focused on transforming special situation challenges into investment opportunities, with a portfolio of ~30 B2B companies across deep tech, digital health, and industrial digitalization.

• Strategic refinement in 2024 led to high-value additions (QuTEM, S4DX) and improved cost efficiency, resulting in a significantly reduced loss year-over-year.

• Maintained financial flexibility by funding operations through selective asset sales and warrant exercises, avoiding further dilution.

Financial highlights

• Group Q4 2024 revenue was 0.0 MSEK (Q4 2023: 0.2 MSEK); full-year 2024 revenue was 0.4 MSEK (2023: 1.0 MSEK).

• Q4 2024 operating profit was -2.9 MSEK (Q4 2023: -4.2 MSEK); full-year operating profit was -11.0 MSEK (2023: -19.0 MSEK).

• Q4 2024 net result was -9.3 MSEK (Q4 2023: -31.2 MSEK); full-year net result was -18.9 MSEK (2023: -52.2 MSEK).

• Portfolio market value at period end was 137 MSEK, down 4.9% from previous quarter, mainly due to conservative revaluations and market declines in pre-seed innovation.

• Cash and cash equivalents at period end were 1.1 MSEK (Q4 2023: 1.4 MSEK).

Outlook and guidance

• Long-term goal remains 30% annual portfolio growth; 2025 expected to be transformative with new transactions and portfolio milestones.

• Anticipates Invite People, S4DX, and QuTEM to reach significant revenue and profitability milestones by H2 2025.

• New long-term plan with updated strategy and KPIs to be presented at the upcoming AGM.